Poon et al. have suggested that a decrease of cyclin A2, rather than increase, promotes tumorigenesis, and once the tumor has developed, high levels of cyclin A2 simply reflect a high proliferation rate, which can explain this inconsistency [49]. The gene discussed is CCNA2; the disease is neoplasm.